Validation of miRNA prognostic significance in stage II colorectal cancer

A protocol for systematic review and meta-analysis of observational clinical studies

Shanthi Sabarimurugan, Chellan Kumarasamy, Madhav Madurantakam Royam, Karthik Lakhotiya, Gothandam Kodiveri Muthukaliannan, Suja Ramalingam, Rama Jayaraj

Research output: Contribution to journalArticleResearchpeer-review

1 Downloads (Pure)

Abstract

Background: Advances in early detection and treatment of colorectal cancer (CRC) has seen marked improvements in recent years. However, it is still the third leading cause of cancer-related deaths worldwide. Although there are studies reporting the significance of miRNAs in stage II colorectal cancer, there is no known comprehensive study utilising collective data from multiple published studies. Thus, this study will focus on performing a systematic review and meta-analysis using published data to identify and underline multiple miRNA targets, with regard to disease prognosis in stage II CRC patients.

Methods: The systematic review will be reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines, 2015 statement. The required articles will be obtained via a search of bibliographical databases such as Cochrane Library, EMBASE, MEDLINE, PubMed, and Web of Science. A set of keywords in multiple permutations will be used for the search. The reference lists of included studies will also be manually searched to further increase the robustness of the search results. The systematic review will primarily be done via a literary synthesis.

Results: Quantitative data synthesis will be based on estimated effect across the studies with forest plots generated to observe pooled outcome measures. A fixed or random-effect model of meta-analysis will be used depending upon the heterogeneity observed between studies. Subgroup analysis will be carried out depending on the availability of sufficient clinical data.

Conclusion: Based on the systematic review and meta-analysis results of this study, the possible miRNAs could be predicted toward the prognosis of stage II colorectal cancer, and specific miRNAs may perhaps be considered as a biomarker and therapeutic target for this malignancy.

Original languageEnglish
Article numbere14570
Pages (from-to)1-8
Number of pages8
JournalMedicine
Volume98
Issue number12
DOIs
Publication statusPublished - 1 Mar 2019

Fingerprint

MicroRNAs
Observational Studies
Meta-Analysis
Colorectal Neoplasms
PubMed
MEDLINE
Libraries
Neoplasms
Biomarkers
Outcome Assessment (Health Care)
Databases
Guidelines
Clinical Studies
Therapeutics

Cite this

Sabarimurugan, S., Kumarasamy, C., Madurantakam Royam, M., Lakhotiya, K., Kodiveri Muthukaliannan, G., Ramalingam, S., & Jayaraj, R. (2019). Validation of miRNA prognostic significance in stage II colorectal cancer: A protocol for systematic review and meta-analysis of observational clinical studies. Medicine, 98(12), 1-8. [e14570]. https://doi.org/10.1097/MD.0000000000014570
Sabarimurugan, Shanthi ; Kumarasamy, Chellan ; Madurantakam Royam, Madhav ; Lakhotiya, Karthik ; Kodiveri Muthukaliannan, Gothandam ; Ramalingam, Suja ; Jayaraj, Rama. / Validation of miRNA prognostic significance in stage II colorectal cancer : A protocol for systematic review and meta-analysis of observational clinical studies. In: Medicine. 2019 ; Vol. 98, No. 12. pp. 1-8.
@article{ee1ebfc8db6c4edaaa0a54f267f35eec,
title = "Validation of miRNA prognostic significance in stage II colorectal cancer: A protocol for systematic review and meta-analysis of observational clinical studies",
abstract = "Background: Advances in early detection and treatment of colorectal cancer (CRC) has seen marked improvements in recent years. However, it is still the third leading cause of cancer-related deaths worldwide. Although there are studies reporting the significance of miRNAs in stage II colorectal cancer, there is no known comprehensive study utilising collective data from multiple published studies. Thus, this study will focus on performing a systematic review and meta-analysis using published data to identify and underline multiple miRNA targets, with regard to disease prognosis in stage II CRC patients. Methods: The systematic review will be reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines, 2015 statement. The required articles will be obtained via a search of bibliographical databases such as Cochrane Library, EMBASE, MEDLINE, PubMed, and Web of Science. A set of keywords in multiple permutations will be used for the search. The reference lists of included studies will also be manually searched to further increase the robustness of the search results. The systematic review will primarily be done via a literary synthesis. Results: Quantitative data synthesis will be based on estimated effect across the studies with forest plots generated to observe pooled outcome measures. A fixed or random-effect model of meta-analysis will be used depending upon the heterogeneity observed between studies. Subgroup analysis will be carried out depending on the availability of sufficient clinical data. Conclusion: Based on the systematic review and meta-analysis results of this study, the possible miRNAs could be predicted toward the prognosis of stage II colorectal cancer, and specific miRNAs may perhaps be considered as a biomarker and therapeutic target for this malignancy.",
author = "Shanthi Sabarimurugan and Chellan Kumarasamy and {Madurantakam Royam}, Madhav and Karthik Lakhotiya and {Kodiveri Muthukaliannan}, Gothandam and Suja Ramalingam and Rama Jayaraj",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/MD.0000000000014570",
language = "English",
volume = "98",
pages = "1--8",
journal = "Medicine",
issn = "0025-7974",
publisher = "Lippincott Williams & Wilkins",
number = "12",

}

Sabarimurugan, S, Kumarasamy, C, Madurantakam Royam, M, Lakhotiya, K, Kodiveri Muthukaliannan, G, Ramalingam, S & Jayaraj, R 2019, 'Validation of miRNA prognostic significance in stage II colorectal cancer: A protocol for systematic review and meta-analysis of observational clinical studies', Medicine, vol. 98, no. 12, e14570, pp. 1-8. https://doi.org/10.1097/MD.0000000000014570

Validation of miRNA prognostic significance in stage II colorectal cancer : A protocol for systematic review and meta-analysis of observational clinical studies. / Sabarimurugan, Shanthi; Kumarasamy, Chellan; Madurantakam Royam, Madhav; Lakhotiya, Karthik; Kodiveri Muthukaliannan, Gothandam; Ramalingam, Suja; Jayaraj, Rama.

In: Medicine, Vol. 98, No. 12, e14570, 01.03.2019, p. 1-8.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Validation of miRNA prognostic significance in stage II colorectal cancer

T2 - A protocol for systematic review and meta-analysis of observational clinical studies

AU - Sabarimurugan, Shanthi

AU - Kumarasamy, Chellan

AU - Madurantakam Royam, Madhav

AU - Lakhotiya, Karthik

AU - Kodiveri Muthukaliannan, Gothandam

AU - Ramalingam, Suja

AU - Jayaraj, Rama

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Background: Advances in early detection and treatment of colorectal cancer (CRC) has seen marked improvements in recent years. However, it is still the third leading cause of cancer-related deaths worldwide. Although there are studies reporting the significance of miRNAs in stage II colorectal cancer, there is no known comprehensive study utilising collective data from multiple published studies. Thus, this study will focus on performing a systematic review and meta-analysis using published data to identify and underline multiple miRNA targets, with regard to disease prognosis in stage II CRC patients. Methods: The systematic review will be reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines, 2015 statement. The required articles will be obtained via a search of bibliographical databases such as Cochrane Library, EMBASE, MEDLINE, PubMed, and Web of Science. A set of keywords in multiple permutations will be used for the search. The reference lists of included studies will also be manually searched to further increase the robustness of the search results. The systematic review will primarily be done via a literary synthesis. Results: Quantitative data synthesis will be based on estimated effect across the studies with forest plots generated to observe pooled outcome measures. A fixed or random-effect model of meta-analysis will be used depending upon the heterogeneity observed between studies. Subgroup analysis will be carried out depending on the availability of sufficient clinical data. Conclusion: Based on the systematic review and meta-analysis results of this study, the possible miRNAs could be predicted toward the prognosis of stage II colorectal cancer, and specific miRNAs may perhaps be considered as a biomarker and therapeutic target for this malignancy.

AB - Background: Advances in early detection and treatment of colorectal cancer (CRC) has seen marked improvements in recent years. However, it is still the third leading cause of cancer-related deaths worldwide. Although there are studies reporting the significance of miRNAs in stage II colorectal cancer, there is no known comprehensive study utilising collective data from multiple published studies. Thus, this study will focus on performing a systematic review and meta-analysis using published data to identify and underline multiple miRNA targets, with regard to disease prognosis in stage II CRC patients. Methods: The systematic review will be reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines, 2015 statement. The required articles will be obtained via a search of bibliographical databases such as Cochrane Library, EMBASE, MEDLINE, PubMed, and Web of Science. A set of keywords in multiple permutations will be used for the search. The reference lists of included studies will also be manually searched to further increase the robustness of the search results. The systematic review will primarily be done via a literary synthesis. Results: Quantitative data synthesis will be based on estimated effect across the studies with forest plots generated to observe pooled outcome measures. A fixed or random-effect model of meta-analysis will be used depending upon the heterogeneity observed between studies. Subgroup analysis will be carried out depending on the availability of sufficient clinical data. Conclusion: Based on the systematic review and meta-analysis results of this study, the possible miRNAs could be predicted toward the prognosis of stage II colorectal cancer, and specific miRNAs may perhaps be considered as a biomarker and therapeutic target for this malignancy.

UR - http://www.scopus.com/inward/record.url?scp=85063608828&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000014570

DO - 10.1097/MD.0000000000014570

M3 - Article

VL - 98

SP - 1

EP - 8

JO - Medicine

JF - Medicine

SN - 0025-7974

IS - 12

M1 - e14570

ER -

Sabarimurugan S, Kumarasamy C, Madurantakam Royam M, Lakhotiya K, Kodiveri Muthukaliannan G, Ramalingam S et al. Validation of miRNA prognostic significance in stage II colorectal cancer: A protocol for systematic review and meta-analysis of observational clinical studies. Medicine. 2019 Mar 1;98(12):1-8. e14570. https://doi.org/10.1097/MD.0000000000014570